Abstract: A superconducting coil having form of pancake or double pancake wound of non-insulated superconducting wire (tape) with insulating layer between adjacent turns composed of epoxy resin filled with ceramic powder of high thermal conductivity. A superconducting coil composed of several pancakes and/or double pancakes and includes layers of said epoxy with or without additional spacers between adjacent pancakes. Pancakes or double pancakes as well as coils, consisting of several pancakes and/or double pancakes that have a solenoid form or racetrack or saddle forms.

Abstract: The invention relates to 5-HT receptor agonists and partial agonists. Novel thienopyridinone compounds represented by Formula I, and synthesis and uses thereof for treating diseases mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include Alzheimer's disease, cognition disorders, irritable bowel syndrome, nausea, emesis, vomiting, prokinesia, gastroesophageal reflux disease, nonulcer dyspepsia, depression, anxiety, urinary incontinence, migraine, arrhythmia, atrial fibrillation, ischemic stroke, gastritis, gastric emptying disorders, feeding disorders, gastrointestinal disorders, constipation, erectile dysfunction, and respiratory depression. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.

Abstract: The invention relates to 5-HT receptor antagonists. Novel piperidinylamino-thieno [2,3-d]pyrimidine compounds represented by Formula I, and synthesis and uses thereof for treating diseases mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include central nervous system disorders such as pulmonary arterial hypertension, migraine, hypertension, disorders of the gastrointestinal tract, restenosis, asthma, obstructive airway disease, prostatic hyperplasia and priapism, anxiety, depression, schizophrenia, neural injury and stroke. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also provided.

Abstract: The invention relates to 5-HT receptor modulators, particularly 5-HT2B antagonists. Novel piperidinylamino-thieno [2,3-d] pyrimidine compounds represented by Formula I, II and III, and uses thereof for treating conditions including pulmonary arterial hypertension, congestive heart failure, and hypertension.

Abstract: The invention relates to 5-HT receptor antagonists. Novel piperidinylamino-thieno[2,3-d]pyrimidine compounds represented by Formula I, and synthesis and uses thereof for treating diseases mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include central nervous system disorders such as anxiety, depression, schizophrenia, neural injury, stroke, and migraine. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.

Abstract: The invention relates to 5-HT receptor agonists or antagonists. Novel arylpiperazinyl sulfonamide compounds represented by Formula I, and synthesis and uses thereof for treating diseases including those mediated directly or indirectly by 5-HT receptors, are disclosed. Such conditions include central nervous system disorders such as generalized anxiety disorder, ADD/ADHD, neural injury, stroke, and migraine. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.

Abstract: An optical transmitter, consisting of a radiation source which is adapted to generate a base optical beam with a base wavelength. The transmitter further consists of at least one modulator which is coupled to modulate the base optical beam so as to generate multiple carrier beams at respective side-bands of the base wavelength and to introduce information into the carrier beams for transmission thereby to a receiver.

Abstract: The invention discloses tachykinin receptor antagonists. The tachykinin family of receptors comprising the neurokinins substance P (SP), neurokinin A, and neurokinin B and related neuropeptides that are widely distributed in the peripheral and central nervous system. The invention discloses novel aminopyrimidine derivatives, synthesis and uses thereof for the treatment of diseases mediated directly or indirectly by the tachykinin receptors. These diseases include central nervous system disorders such as anxiety, pain, depression, emesis, in particular cancer chemotherapy induced emesis, respiratory and inflammatory bowel disease and other gastric disorders, asthma, schizophrenia, ophthalmic diseases such as glaucoma, ocular hypotension, neural injury, stroke, cardiac disorders, psoriasis, and migraine. Methods of preparation and novel intermediates and pharmaceutical salts thereof are also included.

Abstract: A method and apparatus for minimizing spill code in regions of low register pressure determines the register pressure at various locations in the computer program. When a live range is selected for spilling, spill code is generated to relieve the register pressure in regions of high register pressure, while spill code is avoided in regions of low register pressure. In this manner a minimum amount of spill code is generated, enhancing both the compile time and the run time of the resultant instruction stream.

Abstract: A method and device for optimizing a compiler involves cooperation between the global and local register allocators in assigning symbolic registers to hardware registers. A large procedure may have many associated symbolic registers; the invention involves partitioning the symbolic registers into at least two portions, and allowing the global register allocator to assign one portion and the local register allocator to assign another portion. The registers may be partitioned based on different criteria, such as local vs. global registers, or spill costs, or shallow vs. nested regions.

Abstract: A method and apparatus for coloring an interference graph yields a higher number of colored nodes by taking into consideration the colors of neighbors of a node's uncolored constrained neighbors. By assigning a color to a node that is also the color of a neighbor of an uncolored constrained neighbor, one color constraint is removed, increasing the probability of coloring the uncolored constrained neighbor. If more than one of the neighbors of the uncolored constrained neighbors are colored, one of the colors may be selected over the others using an appropriate heuristic.

Abstract: A method and apparatus for truncating runaway lifetimes of program variables calculates liveness for each variable based on upwardly exposed uses. Reaching definitions are then calculated for at least the program variables that have runaway lifetimes. The liveness information is compared to the reaching definition information to determine whether a variable that is live upon entry to a basic block has a definition that reaches the end of each predecessor block, or has a use within the basic block. If the reaching definition for a variable reaches the beginning of the block and if there is a predecessor block for which there is no reaching definition, the variable has a runaway lifetime. The variable also has a runaway lifetime if there is a use of the variable in a block without a reaching definition for the variable at the beginning of the block. The runaway lifetime is truncated by inserting an instruction such as a pseudo-definition of the variable into the instruction stream at an appropriate place.